Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humans

Neuroscience Letters

Volumn 343, Issue 2, 2003, Pages 144-146

  Schmidt, Brian L ^a   Gear, Robert W ^a   Levine, Jon D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti analgesia; Dysesthesia; Kappa opioids; Local anesthetic toxicity; Nerve injury; Opioid antagonism

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CAPSAICIN; CELECOXIB; CLONAZEPAM; GABAPENTIN; NALBUPHINE; NALOXONE; NARCOTIC AGENT;

ADULT; ANALGESIA; ARTICLE; CASE REPORT; CHEMICAL INJURY; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LOW DRUG DOSE; MALE; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA; VISUAL ANALOG SCALE;

EID: 0038662902     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00356-2     Document Type: Article

References (11)

1. Catheline G., Guilbaud G., Kayser V. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats. Eur. J. Pharmacol. 357:1998;171-178.
2. Catheline G., Kayser V., Guilbaud G. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors. Eur. J. Pharmacol. 315:1996;135-143.
3. Fujimoto J.M., Arts K.S., Rady J.J., Tseng L.F. Spinal dynorphin A (1-17): possible mediator of antianalgesic action. Neuropharmacology. 29:1990;609-617.
4. Fujimoto J.M., Rady J.J. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17). J. Pharmacol. Exp. Ther. 251:1989;1045-1052.
5. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., Levine J.D. Action of naloxone on gender-dependent analgesic and antianalgesic effects of nalbuphine in humans. J. Pain. 1:2000;122-127.
6. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., Levine J.D. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain. 83:1999;339-345.
7. Gregg J. Non-surgical management of traumatic neuralgias and sensory neuropathies. Oral Maxillofac. Surg. Clin. N. Am. 4:1992;375-392.
8. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-139.
9. Pogrel M.A., Thamby S. Permanent nerve involvement resulting from inferior alveolar nerve blocks. J. Am. Dent. Assoc. 131:2000;901-907.
10. Rady J.J., Fujimoto J.M. Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice. J. Pharmacol. Exp. Ther. 299:2001;659-665.
11. Zola E.M., McLeod D.C. Comparative effects and analgesic efficacy of the agonist-antagonist opioids. Drug Intell. Clin. Pharm. 17:1983;411-417.